National Collaboration to Reduce Practice Variation
In 2013 The Canadian Association of Paediatric Health Centres (CAPHC), in partnership with Medbuy established a National Collaborative to develop guidelines for the use of inhaled nitric oxide (iNO) in neonatal and paediatric patients. This Collaborative included content experts: physicians, respiratory therapists, nurses and quality improvement leaders from across the country.
CAPHC and the Inhaled Nitric Oxide Collaborative are proud to announce that the CAPHC Guidelines for Inhaled Nitric Oxide for both Neonates and Paediatrics: Dosing, Administration and Weaning, are now posted on the CAPHC Knowledge Exchange Network.
We believe that the implementation of these national standards will:
- Provide a focus for quality control and patient safety;
- Reduce variations in practice; and
- Promote efficient use of inhaled nitric oxide.
"This achievement and key milestone would not be possible without the collective effort of each expert member of our collaborative. This work is a product of everyone`s exemplary collaboration and commitment to excellence in patient care." Zelia Da Silva, iNO Collaborative Co-chair
To learn more about the iNO Collaborative, the guideline development process, and to view and download the guidelines please go to CAPHC iNO Collaborative Guidelines